Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02989818 · ClinicalTrials.gov registry record

Multi-center Evaluation of the Clinical Utility of ESD in the Western Population

A clinical trial of Endoscopic Submucosal Dissection, sponsored by University of Florida.

Recruiting
Registry status
300
Enrollment target
3
Study locations

NCT02989818: Recruiting study of Endoscopic Submucosal Dissection, sponsored by University of Florida.

NCT02989818 is a study of Endoscopic Submucosal Dissection that is actively recruiting participants, run by University of Florida. The registered enrollment target is 300 participants. The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02989818, a study of Endoscopic Submucosal Dissection, is actively recruiting participants, sponsored by University of Florida.

RECRUITING
Registry status
300 participants
Enrollment target
3
Study locations

Study Summary

The aim of this multi-center study is to prospectively document the clinical utility of ESD.

Primary Outcome

An Excision of the targeted lesion in a single specimen

Interventions

  • OTHER Endoscopic Submucosal Dissection

Study Locations (3)

Florida

  • University of Florida - Gainesville

Massachusetts

  • Massachusetts General Hospital - Boston

Texas

  • Baylor College of Medicine - Houston

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2016-03
Est. Completion 2026-01
University of Florida

1,106 total trials

What NCT02989818 shows while recruiting

NCT02989818 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.

The record links to 1 condition, with Endoscopic Submucosal Dissection appearing as the primary indexed condition, and to 1 intervention - of which Endoscopic Submucosal Dissection is the first listed.

NCT02989818 reports a single indexed study location in Florida, Massachusetts, Texas.

Frequently Asked Questions

What is clinical trial NCT02989818 about?

NCT02989818 is a clinical study titled "Multi-center Evaluation of the Clinical Utility of ESD in the Western Population". The aim of this multi-center study is to prospectively document the clinical utility of ESD.

What is the current status of trial NCT02989818?

This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2016-03. Estimated completion is 2026-01.

What conditions does trial NCT02989818 study?

This clinical trial studies the following conditions: Endoscopic Submucosal Dissection.

What interventions are being tested in trial NCT02989818?

The interventions under investigation include: Endoscopic Submucosal Dissection (OTHER).

Who is sponsoring clinical trial NCT02989818?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02989818 being conducted?

This trial has 3 study locations across Florida, Massachusetts, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Endoscopic Submucosal Dissection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02989818, the US trial registry maintained by the National Library of Medicine. NCT02989818 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.